Telitacicept for IgA Nephropathy Interim Analysis of a Phase 3 Trial — Clinical Reference Card Source: Li et al., NEJM 2024 | Specialty: Nephrology 🎯 EXECUTIVE SUMMARY Telitacicept is a novel recom…